Related Experiment Video
Updated: Jul 31, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
First serological evidence of MERS-CoV in dromedary camels from Algeria
Mohamed Anis Haroun1, Maamar Khames2, Said Fettata3
1Laboratory of Biology and Experimental Pharmacology, University of Medea, Algeria.
Abstract:
Middle East Respiratory Syndrome (MERS) is a zoonotic disease. Dromedary camel is responsible of its transmission to humans. Accordingly, several human cases have been reported worldwide with a high mortality rate. In Algeria, no data reported on MERS prevalence in camels. This is a first seroprevalence study MERS-CoV in Algerian dromedaries. A total of 87 camel blood samples from EL -MENIAA and Ghardaia, were analyzed by anti-MERS-CoV IgG ELISA camel. The seroprevalence was 64 % and it significantly increases with age. Larger serological and molecular screening is needed to precisely determine the rate of MERS active circulation among Algerian dromedary population.
More Related Videos
Related Concept Videos
Rocky Mountain Spotted Fever
Rabies

